Switch to:
More From Other Websites
Edison Issues ADR Update on Novogen (NVGN) Sep 11 2017
Australian cancer specialists may hold key to next advancement in ovarian cancer treatment Aug 30 2017
GDC-0084 Progress Update: On Track for Phase II Commencement in 2017 Aug 22 2017
Board Review of Business Operations and Governance Aug 14 2017
Progress Update on Cantrixil(TM) (TRXE-002-1) Development Aug 07 2017
Democrats found a way to speak Trump's language in pharma debate Apr 04 2017
Novogen Receives $4.4M R&D Tax Rebate Mar 27 2017
Transformation to a Clinical Stage Organisation Leads to Changes in Management Structure Mar 10 2017
Novogen Awarded Grant of up to A$3m by Australian Federal Government for Novel Drug Discovery... Mar 06 2017
Novogen Licenses Phase II-ready Molecule from Genentech for Development in Glioblastoma for $5M... Oct 30 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK